Abstract
Purpose
We investigated whether the initial CT distribution of metastatic disease is predictive of overall survival in patients with stage IV colorectal cancer.
Materials and methods
A retrospective study of 65 patients (37 males, 28 females, mean age 56, range 28–88 years) with stage IV colorectal cancer was derived from an institutional database. Inclusion criteria required KRAS mutation testing and pretreatment CT examinations to be available (65 abdomen/pelvis, 63 chest). Disease burden was jointly characterized by two radiologists in consensus. Median follow-up was 39 months (range 8–115 months). Survival was assessed using Cox proportional hazards models.
Results
Univariate analysis showed that stratified site(s) of measurable disease and counts of measurable lesions ≥1 cm in the liver, peritoneum, and retroperitoneum were statistically significant risk factors for overall mortality [univariate HR 8.2 (CI 2.7–25.4) for isolated peritoneal disease, HR 1.11 per 5 lesions (CI 1.05–1.17) for liver lesions, HR 1.15 per lesion (CI 1.05–1.26) for peritoneal lesions, and HR 1.11 (CI 1.03–1.19) for retroperitoneal lymph nodes ≥1 cm in short axis]. The stratified site(s) of disease and counts of measurable liver lesions remained significant in the multivariate model (p < 0.0001 for isolated peritoneal disease and count of liver lesions). Thoracic metastases were not statistically significant predictors of overall mortality in this cohort.
Conclusion
This study identified site(s) of measurable metastasis and counts of measurable liver lesions as independent predictors of overall survival. These findings may have value for future prognostic assessments once validated in a larger, independent, and potentially prospective cohort.
Similar content being viewed by others
References
American Cancer Society (2012) Cancer Facts and Figures. Atlanta: American Cancer Society
Edge SB, Byrd DR, Compton CC, et al. (2010) AJCC Cancer Staging Manual, 7th edn. New York: Springer
Stangl R, Altendorf-Hofmann A, Charnley RM, Scheele J (1994) Factors influencing the natural history of colorectal liver metastases. Lancet 343(8910):1405–1410
Howlader N, Noone A, Krapcho M, et al. (2013) SEER Cancer Statistics Review, 1975–2011. Bethesda: National Cancer Institute
Gunderson LL, Jessup JM, Sargent DJ, Greene FL, Stewart AK (2010) Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol 28(2):264–271. doi:10.1200/JCO.2009.24.0952
Poston GJ, Figueras J, Giuliante F, et al. (2008) Urgent need for a new staging system in advanced colorectal cancer. J Clin Oncol 26(29):4828–4833. doi:10.1200/JCO.2008.17.6453
Eisenhauer EA, Therasse P, Bogaerts J, et al. (2009) New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1). Eur J Cancer 45(2):228–247. doi:10.1016/j.ejca.2008.10.026
Shepherd NA, Baxter KJ, Love SB (1997) The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation. Gastroenterology 112(4):1096–1102
Kennecke HF, Yu J, Gill S, Cheung WY, Blanke CD, Cheifetz R, Woods R (2013) Impact of M1a and M1b staging in patients (pts) with metastatic colorectal cancer. ASCO Annual Meeting Abstract. J Clin Oncol 31(15 Supplement):3590. http://meeting.ascopubs.org/cgi/content/abstract/31/15_suppl/3590
Benson AB III, NCCN Guidelines Panel for Colon Cancer (2014) NCCN Clinical Practice Guidelines in Oncology. USA: NCCN
Dewhurst C, Rosen M, Blake M, Baker M, Cash B, Fidler J, Greene FL, Hindman N, Jones B, Katz D, Lalani T, Miller F, Small W, Sudakoff G, Tulchinsky M, Yaghmai V, Yee J (2014) ACR Appropriateness Criteria for pretreatment staging of colorectal cancer. American College of Radiology. http://www.acr.org/~/media/ACR/Documents/AppCriteria/Diagnostic/PretreatmentStagingColorectalCancer.pdf. Accessed 3 June 2014
Compton CC, Fielding LP, Burgart LJ, et al. (2000) Prognostic factors in colorectal cancer. Arch Pathol Lab Med 124(7):979–994
Lan YT, Yang SH, Chang SC, et al. (2012) Analysis of the seventh edition of American Joint Committee on colon cancer staging. Int J Colorectal Dis 27(5):657–663. doi:10.1007/s00384-011-1366-6
Zacharakis M, Xynos ID, Lazaris A, et al. (2010) Predictors of survival in stage IV metastatic colorectal cancer. Anticancer Res 30(2):653–660
Imamura Y, Morikawa T, Liao X, et al. (2012) Specific mutations in KRAS codons 12 and 13, and patient prognosis in 1075 BRAF wild-type colorectal cancers. Clin Cancer Res 18(17):4753–4763. doi:10.1158/1078-0432.CCR-11-3210
Acknowledgments
This work was supported in part by National Institutes of Health grants 5P50CA127003, R01CA149222, R01CA118553, and National Cancer Institute Cancer Center Support Grant 5P30CA06516.
Conflict of interest
The authors report no conflicts of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Rosenthal, M.H., Kim, K.W., Fuchs, C.S. et al. CT predictors of overall survival at initial diagnosis in patients with stage IV colorectal cancer. Abdom Imaging 40, 1170–1176 (2015). https://doi.org/10.1007/s00261-014-0272-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00261-014-0272-0